Comparison of Accuracy and Safety of the SEVEN and the Navigator Continuous Glucose Monitoring Systems
- 1 February 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 11 (2), 65-72
- https://doi.org/10.1089/dia.2008.0109
Abstract
Objective: This study evaluated the accuracy and safety of two continuous glucose monitoring (CGM) systems, the SEVEN® (DexCom™, San Diego, CA) and the Navigator® (Abbott Diabetes Care, Alameda, CA), with the YSI laboratory measurements of blood glucose (blood glucose meter manufactured by YSI, Yellow Springs, OH), when worn concurrently in adults with type 1 diabetes. Design and Methods: Fourteen subjects with type 1 diabetes, 33 ± 6 (mean ± SD) years old, were enrolled in this study. All subjects wore both sensors concurrently over three consecutive 5-day CGM sessions (15-day wear). On Days 5, 10, and 15, subjects participated in an 8-h in-clinic session where measurements from the CGM systems were collected and compared with YSI measurements every 15 min. At the end of Day 5 and 10 in-clinic sessions, the sensors were removed, and new sensors were inserted for the following CGM session despite the SEVEN system's recommended use for up to 7 days. Results: The mean absolute relative difference (ARD) for the two CGM devices versus YSI was not different: 16.8% and 16.1% for SEVEN and Navigator, respectively (P = 0.38). In the hypoglycemic region (YSI value P = 0.001). The data analyses were similar when compared with self-monitoring of blood glucose (SMBG) values. Thirteen additional Navigator replacement devices were issued compared to two for the SEVEN. A total of three versus 14 skin reactions were reported with the SEVEN and Navigator insertion area, respectively. Conclusions: Glucose measurements with the SEVEN and Navigator were found to be similar compared with YSI and SMBG measurements, with the exception of the hypoglycemic range where the SEVEN performed better. However, the Navigator caused more skin area reactions.Keywords
This publication has 8 references indexed in Scilit:
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesThe New England Journal of Medicine, 2008
- Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring SystemDiabetes Care, 2007
- Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose SensorDiabetes Care, 2006
- Evaluating the Accuracy of Continuous Glucose-Monitoring SensorsDiabetes Care, 2004
- Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison With Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life ConditionsDiabetes Care, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialAmerican Journal Of Medicine, 1991
- Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood GlucoseDiabetes Care, 1987